MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Common Stock Repurchased
Cash spent buying back the company's own shares.
MetLife, Inc.NYSE: MET
Common Stock Repurchased · Q2 FY2026 · quarter ended Jun 2026
Common stock repurchased growth accelerates
Q2 FY2026 common stock repurchased of $722M (cash outflow) rose 41.6% year over year, ahead of the -21.3% change in trailing-twelve-month common stock repurchased. Sequentially, it fell 4.4% from the prior quarter. Over 3 fiscal years it compounded at +5.3% a year.
Context
- Common stock repurchased amounted to 5.0% of revenue in FY2025, up 0.5 pp from a year earlier.
- Common stock repurchased grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +41.6% holds above the trailing-twelve-month pace of -21.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Repurchased history
USD · from the cash flow
- Latest · FY2025
- (3.88B) USD
- Year-over-year change
- -21.1%
| Period | Period end | Common Stock Repurchased | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (3.88B) | -21.1% |
| FY2024 | 2024-12-31 | (3.21B) | -3.4% |
| FY2023 | 2023-12-31 | (3.1B) | +6.7% |
| FY2022 | 2022-12-31 | (3.33B) | +30.8% |
| FY2021 | 2021-12-31 | (4.8B) | — |
Common Stock Repurchased vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -21.3% is the 7th highest of 10, against a peer median of -0.3%.
- Common stock repurchased amounts to 3.1% of revenue for MET, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.79B USD | +27.1% | +13.7% | 20.9% | |
| LTM Jun 2026 | $2.44B USD | -21.3% | +5.3% | 3.1% | |
| LTM Jun 2026 | CA$1.24B CAD | -65.3% | +8.8% | 2.1% | |
| LTM Jun 2026 | $1.12B USD | -4.7% | +71.6% | 8.4% | |
| LTM Jun 2026 | $1B USD | -0.3% | -12.4% | 1.5% | |
| LTM Jun 2026 | $881.32M USD | -23.9% | +24.7% | 14.2% | |
| LTM Jun 2026 | $500M USD | +71.2% | -35.6% | 13.3% | |
| LTM Jun 2026 | $469.25M USD | +9.7% | +8.1% | 13.8% | |
| LTM Jun 2026 | $255M USD | -35.0% | +20.4% | 5.5% | |
| LTM Sep 2026 | $161M USD | +168.3% | -40.7% | 3.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding MET) | — | -0.3% | +8.8% | 7.0% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 6.55B | 5.28B | 1.58B | 4.43B | 3.38B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 2.64B | 1.9B | 2.18B | 1.85B | 6.84B |
| Accounts Receivables | 362M | 299M | 0 | 460M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 2.27B | 1.6B | 2.18B | 1.39B | 6.84B |
| Other Non-Cash Items | 2.94B | 3.52B | 9.78B | 8.13B | 7.14B |
| Operating Cash Flow | 12.83B | 11.37B | 14.26B | 15.12B | 18.11B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | 3.27B | (709M) | (755M) | (358M) | (738M) |
| Purchases of Investments | (109.32B) | (104.64B) | (84.27B) | (82.14B) | (105.7B) |
| Sales of Investments | 110.79B | 108.43B | 76.1B | 69.94B | 92.87B |
| Other Investing Activities | (20.29B) | (5.7B) | (143M) | 1.07B | (2.04B) |
| Investing Cash Flow | (11.19B) | (2.62B) | (10.25B) | (11.49B) | (15.61B) |
| Debt Repayment | (632M) | 878M | 875M | (982M) | (566M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (4.8B) | (3.33B) | (3.1B) | (3.21B) | (3.88B) |
| Dividends Paid | (1.84B) | (1.78B) | (1.76B) | (1.73B) | (1.7B) |
| Other Financing Activities | 5.9B | (5.72B) | 1.05B | 2.79B | 6.32B |
| Financing Cash Flow | (1.38B) | (9.95B) | (2.94B) | (3.13B) | 163M |
| Effect of Forex Changes | (13M) | 1.34B | (630M) | (1.06B) | (697M) |
| Net Change in Cash | 252M | 148M | 444M | (571M) | 1.96B |
| Free Cash Flow | 12.83B | 11.37B | 14.26B | 15.12B | 18.11B |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.